SMAD2 and neoplasm: Tumor xenografts treated with DMH2 for 24 h and 9 days showed activation of TAK1 and TGFβ signaling as demonstrated by an increase in phosphorylated TAK1 and Smad2 respectively (Fig. 2a and b).